Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations
Year: 2024
Type: article
Source: Leukemia
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Health and Human Services, Alex's Lemonade Stand Foundation for Childhood Cancer, Leukemia and Lymphoma Society, University of Pennsylvania, University of Michigan, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, Center for Scientific Review
Awards: G1331102704, G1524076426, G1789528360, G1839525577, G1898258265, G206706323, G267878863, G289418584, G2989326787, Targeting Menin in Acute Leukemia with Upregulated HOX Genes, G3468390704, G3854045482, G4097551151, G4539696440, G4703636488, G5520316217, G565236188, Development of ASH1L inhibitors for acute leukemia, Targeting NSD1 in leukemia, G7421106163, Omics interrogation of functionally competent hematopoieitic stem cells, G771006173, G7786140461, G7913375334, G7991655340, Development of novel anti-leukemia agents targeting the menin-MLL interaction, G9000219241, Targeting PRC1 in leukemia
OpenAlex ID: W4399775646